Darshan Doshi on Results of iMODERN and ILIAS ANOCA Studies Presented at TCT 2025
Darshan Doshi, Chief Medical Officer for Image-Guided Therapy Devices at Philips, shared on LinkedIn:
”Proud to share that today at TCT 2025, Philips has announced the 3-year results from the iMODERN trial, the largest global study to date using Class IA-recommended iFR in heart attack patients with multi-vessel disease.
This late-breaking data confirms that treating additional blocked arteries during the initial procedure is just as safe as waiting for a follow-up, giving clinicians more flexibility to personalize care and potentially reduce additional hospital visits.
These results directly address a longstanding question in interventional cardiology and reinforce the evidence base for physiology-guided treatment strategies.
In addition, new results from the ILIAS ANOCA study, also presented at TCT, highlight the sustained benefits of physiology-guided assessment and tailored medical therapy for patients with angina but no obstructive coronary arteries.
Together, these studies underscore the value of integrating advanced physiology solutions in decision-making across the spectrum of cardiovascular care.
Congratulations to the iMODERN and ILIAS ANOCA teams, and sincere thanks to the investigators and patients who made this research possible.
Read more in the press release.”
Stay updated with Hemostasis Today.
-
Sep 24, 2026, 12:56Maria Helena Parrinello: A New Score for Chronic GvHD Risk Assessment at the SIE Congress
-
Sep 24, 2026, 12:44Shehab Mohamed: TP53 Mutations and Outcomes in Myeloproliferative Neoplasms
-
Sep 24, 2026, 12:34Francesca Palandri: Is There Still a Place for Splenectomy in ITP in the Modern Era?
-
Sep 24, 2026, 12:15Cedric Hermans: RPTH Illustrated Review on Von Willebrand Disease
-
Sep 24, 2026, 11:48Factor XII Inhibition and the Future of Contact Pathway Targeting
-
Sep 24, 2026, 08:55Andres Gudino: Clot Characterization Through Hounsfield Units in Ischemic Stroke
-
Sep 24, 2026, 06:52Gina Sado: Screening-Detected Atrial Fibrillation Carries High Risk of Heart Failure
-
Sep 24, 2026, 06:33Benjamin Vipler: Optimal Oral Anticoagulation Choice in Atrial Fibrillation and Advanced CKD
-
Sep 24, 2026, 06:08Christopher Salerno: AI-Powered At-Home Anemia Screening Advances Telehealth Access